2025 CPT code 90734

Administration of a quadrivalent meningococcal conjugate vaccine (MenACWY-D or MenACWY-CRM) protecting against serogroups A, C, W, and Y.

* Report separately for vaccine administration, the vaccine product itself, and any office visit.* Check payer-specific guidelines for vaccine reporting and modifier requirements.* Do not report 90476-90759 with 90480 unless both a SARS-CoV-2 vaccine and a vaccine from 90476-90759 were administered.

Modifiers may apply depending on the specific circumstances of the vaccination. Consult payer guidelines.

Routine vaccination for adolescents (11-18 years), booster at 16,and for those at high risk of meningococcal disease (e.g., travel to high-risk areas, immunocompromised individuals).

The provider assesses the patient's suitability for vaccination, discusses risks and benefits with the patient or guardian, and administers the vaccine intramuscularly.

IMPORTANT Separate codes exist for other meningococcal vaccines (e.g., those targeting only serogroup B or C).If a specific vaccine code is unavailable, use the unlisted procedure code.

In simple words: This code covers giving a shot of a medicine that protects against four types of bacteria that can cause serious illnesses like meningitis (brain and spinal cord infection) and blood poisoning (septicemia). The doctor talks to you about the shot's benefits and risks before giving it.

This CPT code, 90734, represents the administration of a quadrivalent meningococcal conjugate vaccine, protecting against serogroups A, C, W, and Y.The vaccine is available in two formulations:one with a diphtheria toxoid carrier (MenACWY-D) and another with a CRM197 carrier (MenACWY-CRM).The administration is intramuscular, typically in the deltoid muscle.The code includes the provider's assessment of the patient's suitability for vaccination, discussion of risks and benefits, and the actual administration of the vaccine.Separate codes are required for the vaccine product itself and any associated office visit.

Example 1: An 11-year-old receives their first dose of MenACWY vaccine as part of routine adolescent immunizations., A 16-year-old receives a booster dose of MenACWY vaccine., A college student traveling abroad to a region with a high incidence of meningococcal disease receives a dose of MenACWY vaccine before departure.

* Patient's age and medical history.* Type of vaccine administered (MenACWY-D or MenACWY-CRM).* Administration route (intramuscular).* Date of administration.* Documentation of informed consent.* Any adverse reactions noted.

** The code reflects the most recent US vaccine abbreviation references used in ACIP recommendations at the time of CPT code set publication. Interim updates will be made via the AMA CPT website.

  • Revenue Code: T2D (OTHER TESTS - OTHER)
  • Payment Status: Active
  • Modifier TC rule: Not applicable.
  • Specialties:Pediatrics, Adolescent Medicine, Family Medicine, Internal Medicine, Infectious Disease
  • Place of Service:Office, Outpatient Hospital, School, Other Place of Service
** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.